Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88,059,438
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
25,401,939
-
Shares change
-
+1,565,613
-
Total reported value, excl. options
-
$533,388,213
-
Value change
-
+$25,544,214
-
Number of buys
-
49
-
Number of sells
-
-27
-
Price
-
$20.99
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2021
97 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q2 2021.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,401,939 shares
of 88,059,438 outstanding shares and own 28.85% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3,266,255 shares), Canaan Partners X LLC (2,660,713 shares), BlackRock Inc. (2,602,405 shares), BOXER CAPITAL, LLC (2,202,812 shares), Avidity Partners Management LP (2,070,000 shares), 5AM Venture Management, LLC (1,798,066 shares), FEDERATED HERMES, INC. (1,636,939 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,309,977 shares), VANGUARD GROUP INC (1,070,934 shares), and Alphabet Inc. (753,187 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.